Growth Metrics

Amylyx Pharmaceuticals (AMLX) Amortizatization of Intangibles (2021 - 2025)

Historic Amortizatization of Intangibles for Amylyx Pharmaceuticals (AMLX) over the last 5 years, with Q3 2025 value amounting to $1.2 million.

  • Amylyx Pharmaceuticals' Amortizatization of Intangibles fell 4607.38% to $1.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.3 million, marking a year-over-year decrease of 4114.88%. This contributed to the annual value of $9.9 million for FY2024, which is 84.51% down from last year.
  • Amylyx Pharmaceuticals' Amortizatization of Intangibles amounted to $1.2 million in Q3 2025, which was down 4607.38% from $1.5 million recorded in Q2 2025.
  • Amylyx Pharmaceuticals' Amortizatization of Intangibles' 5-year high stood at $3.2 million during Q2 2024, with a 5-year trough of -$98000.0 in Q4 2021.
  • Over the past 5 years, Amylyx Pharmaceuticals' median Amortizatization of Intangibles value was $1.8 million (recorded in 2022), while the average stood at $1.6 million.
  • Its Amortizatization of Intangibles has fluctuated over the past 5 years, first skyrocketed by 14525000.0% in 2023, then crashed by 5207.68% in 2025.
  • Amylyx Pharmaceuticals' Amortizatization of Intangibles (Quarter) stood at -$98000.0 in 2021, then soared by 1997.96% to $1.9 million in 2022, then soared by 38.28% to $2.6 million in 2023, then crashed by 30.37% to $1.8 million in 2024, then tumbled by 30.6% to $1.2 million in 2025.
  • Its Amortizatization of Intangibles stands at $1.2 million for Q3 2025, versus $1.5 million for Q2 2025 and $1.7 million for Q1 2025.